Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature
Open Access
- 11 August 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1251866
Abstract
Background: Published data on the relationship between polycystic ovary syndrome (PCOS) and thyroid dysfunction are sparse and confusing.Objective: To comprehensively review data available in the literature regarding the relationship between PCOS and the thyroid function, and its abnormalities.Methods: Nine main areas of interest were identified and analyzed according to the available evidence: 1) Evaluation of thyroid function for PCOS diagnosis; 2) Epidemiology data on thyroid function/disorders in patients with PCOS, and vice versa; 3) Experimental data supporting the relationship between thyroid function/disorders and PCOS; 4) Effects of thyroid function/disorders on PCOS features, and vice versa; 5) Effect of thyroid alterations on the cardiometabolic risk in women with PCOS; 6) Effect of thyroid abnormalities on reproductive outcomes in women with PCOS; 7) Relationship between thyroid function/abnormalities in patients with PCOS who are undergoing fertility treatment; 8) Effect of treatments for thyroid diseases on PCOS; and 9) Effect of treatments for PCOS on thyroid function. An extensive literature search for specific keywords was performed for articles published from 1970 to March 2023 using PubMed and Web of Science. Data were reported in a narrative fashion.Results: PCOS is a diagnosis of exclusion for which diagnosis is possible only after excluding disorders that mimic the PCOS phenotype, including thyroid dysfunctions. However, the tests and the cutoff values used for this are not specified. Many experimental and clinical data suggest a relationship between perturbations of the thyroid function and PCOS. Direct and unequivocal evidence on the effects of thyroid function/disorders on PCOS features are lacking. High thyroid-stimulating hormone levels and subclinical hypothyroidism may be associated with significant worsening of several intermediate endpoints of cardiometabolic risk in women with PCOS. Thyroid abnormalities may worsen reproductive outcomes, especially in patients undergoing fertility treatment. To date, there are no data demonstrating the efficacy of thyroid medications on fertility and cardiometabolic risk in women with PCOS. Lifestyle modification changes, metformin, and vitamin D seem to improve thyroid function in the general population.Conclusion: PCOS and thyroid disorders are closely related, and their coexistence may identify patients with a higher reproductive and metabolic risk. Regular screening for thyroid function and thyroid-specific autoantibodies in women with PCOS, particularly before and during pregnancy, is highly recommended.Keywords
This publication has 217 references indexed in Scilit:
- The Role of TGF-β in Polycystic Ovary SyndromeReproductive Sciences, 2014
- Subclinical elevations of thyroid-stimulating hormone and assisted reproductive technology outcomesFertility and Sterility, 2011
- Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic reviewHuman Reproduction Update, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndromeFertility and Sterility, 2010
- A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndromeFertility and Sterility, 2010
- Estradiol targets T cell signaling pathways in human systemic lupusClinical Immunology, 2009
- Serum TSH and Total T 4 in the United States Population and Their Association With Participant Characteristics: National Health and Nutrition Examination Survey (NHANES 1999–2002)Thyroid®, 2007
- Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?Diabetes Care, 1999
- Ovarian LH/hCG receptors and plasma level of LH,17-ß estradiol and progesterone in gonadotropin — induced PCO syndrome in ratsExperimental and Clinical Endocrinology & Diabetes, 1994